| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |